Subscribe to RSS
DOI: 10.1055/a-2335-4444
Spirocyclic Hybrids of Nortropane and 1,3-Oxazinan-2-one Fragments
This research was supported by I.F. Lab Ltd. (Internal grant 00050-z01737).
Abstract
We report facile and versatile procedures for the synthesis of exo- and endo-isomeric spirocyclic hybrids of pharmacophoric (1R,5S)-8-azabicyclo[3.2.1]octane (nortropane) and 1,3-oxazinan-2-one fragments. Our approach consists of the hydrocyanation of endo- and exo-isomeric N-Cbz-protected nortropane-3-spiroepoxides, the reduction of hydroxy nitriles into amino alcohols, the synthesis of N-alkylated amino alcohols via reductive amination, the spirocyclization of the amino alcohols, N-alkylation of the unsubstituted 1,3-oxazinan-2-one fragment in the spiro compounds, and removal of the Cbz protecting groups.
Key words
nortropane - 1,3-oxazinan-2-one - oxiranes - hydrocyanation - reduction - reductive amination - spirocyclization - alkylationSupporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/a-2335-4444.
- Supporting Information
Publication History
Received: 23 April 2024
Accepted after revision: 29 May 2024
Accepted Manuscript online:
29 May 2024
Article published online:
08 July 2024
© 2024. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1a Kohnen-Johannsen KL, Kayser O. Molecules 2019; 24: 796
- 1b Grynkiewicz G, Gadzikowska M. Pharm. Rep. 2008; 60: 439
- 1c Afewerki S, Wang J.-X, Liao W.-W, Córdova A. Alkaloids 2019; 81: 151
- 2a Buels KS, Fryer AD. In Muscarinic Receptors, Handbook of Experimental Pharmacology 208 . Fryer AD, Christopoulos A, Nathanson NM. Springer; Berlin: 2012: 317-341
- 2b Kruse AC, Kobilka BK, Gautam D, Sexton PM, Christopoulos A, Wess J. Nat. Rev. Drug Discovery 2014; 13: 549
- 3 Mandala D, Thompson WA, Watts P. Tetrahedron 2016; 72: 3389
- 4 Chupakhin E, Babich O, Prosekov A, Asyakina L, Krasavin M. Molecules 2019; 17: 4165
- 5 Hiesinger K, Dar’in D, Proschak E, Krasavin M. J. Med. Chem. 2021; 64: 150
- 6a Elderfield RC, Gilman RE. Phytochemistry 1972; 11: 339
- 6b Yang J, Wearing XZ, Le Quesne PW, Deschamps JR, Cook JM. J. Nat. Prod. 2008; 71: 1431
- 7a Bertholdt H, Pfleger R, Schulz W. Arzneim.-Forsch. 1967; 17: 719
- 7b Pak RW, Petrou SP. Curr. Urol. Rep. 2003; 4: 436
- 8a Fernandes GF. S, Scarim CB, Kim S.-H, Wu J, Castagnolo D. RSC Med. Chem. 2023; 14: 823
- 8b Brickner SJ, Barbachyn MR, Hutchinson DK, Manninen RP. J. Med. Chem. 2008; 51: 1981
- 9a Evason K, Huang C, Yamben I, Covey DF, Kornfeld K. Science 2005; 307: 258
- 9b Lewis RT, Macleod AM, Merchant KJ, Kelleher F, Sanderson I, Herbert RH, Cascieri MA, Sadowski S, Ball RG, Hoogsteen K. J. Med. Chem. 1995; 38: 923
- 9c Momose Y, Maekawa T, Yamano T, Kawada M, Odaka H, Ikeda H, Sohda T. J. Med. Chem. 2002; 45: 1518
- 10a Galvez E, Martinez M, Trigo GG, Lopez MV, Florencio F, Smith-Verdier P, Garcia-Blanco S. J. Mol. Struct. 1983; 99: 247
- 10b Maillard J, Langlois M, Delaunay P, Vo Van T, Garcia GS, Lannoy J, Roussillon JL, Morin R, Eskenazi P. Chim. Ther. 1972; 7: 458
- 11 Takehide N, Kanno S, Hiroaki M, Toru T. JP2005097125A, 2005
- 12 Brain CT, Cho YS, Giraldes JW, Lagu B, Levell J, Luzzio M, Perez LB, Wang Y, Yang F. WO2011101409A1, 2011
- 13 Nishi T, Shimada K, Maeda H, Tatsuta T. WO2003084966A1, 2003
- 14 Qiu Y.-L, Peng X, Gao X, Li W, Cao H, Suh B.-C, Kass J, Zhang J, Or YS. WO2020247561A1, 2020
- 15a Wang G. Med. Chem. 2008; 7: 32
- 15b McElroy CR, Aricò F, Benetollo F, Tundo P. Pure Appl. Chem. 2011; 84: 707
- 15c Zhang G, Favela D, Chow WL, Iyer RN, Pell AJ, Olson DE. Org. Lett. 2022; 24: 6208
- 15d Xu Z, Tice CM, Zhao W, Cacatian S, Ye Y.-J, Singh SB, Lindblom P, McKeever BM, Krosky PM, Kruk BA. J. Med. Chem. 2011; 54: 6050
- 15e Trifunović S, Dimitrijević D, Vasić G, Radulović N, Vukićević M, Heinemann FW, Vukićević RD. Synthesis 2010; 943
- 15f Aricò F, Bravo S, Crisma M, Tundo P. Pure Appl. Chem. 2016; 88: 227
- 15g Wang G, Ella-Menye J. -R, Sharma V. Bioorg. Med. Chem. Lett. 2006; 16: 2177
- 16a Mandzhulo A, Vashchenko I, Gerasov A, Vovk M, Rusanov E, Fetyukhin V, Lukin O, Shivanyuk A. Org. Chem. Front. 2019; 6: 1692
- 16b Fei Z, Wu Q, Zhang F, Cao Y, Liu C, Shieh W.-C, Xue S, McKenna J, Prasad K, Prashad M, Baeschlin D, Namoto K. J. Org. Chem. 2008; 73: 9016
- 16c Schlienger N, Lund BW, Pawlas J, Badalassi F, Bertozzi F, Lewinsky R, Fejzic A, Thygesen MB, Tabatabaei A, Bradley SR, Gardell LR, Piu F, Olsson R. J. Med. Chem. 2009; 52: 7186
- 16d Kubas H, Meyer U, Hechenberger M, Klein K.-U, Plitt P, Zemribo R, Spexgoor HW, van Assema SG. A, Abel U. Bioorg. Med. Chem. Lett. 2013; 23: 6370
- 16e Bream RN, Hayes D, Hulcoop DG, Whiteman AJ. Org. Process Res. Dev. 2013; 17: 641
- 16f Bollinger S, Huebner H, Heinemann FW, Meyer K, Gmeiner P. J. Med. Chem. 2010; 53: 7167
- 16g Holson E, Wagner FF, Weiwer M, Scolnick E, Palmer M, Dordevic L, Lewis M, Pan JQ, Zhang Y.-L, Xu Q. WO2016100940, 2015
- 16h Li J, Liu M, Li Y, Sun D.-D, Shu Z, Tan Q, Guo S, Xie R, Gao L, Ru H, Zang Y, Liu H, Li J, Zhou Y. J. Med. Chem. 2020; 63: 12748
- 17 Smith GM. T, Burton PM, Bray CD. Angew. Chem. Int. Ed. 2015; 54: 15236
- 18 Mandzhulo AYu, Mel’nichuk NA, Fetyukhin VN, Vovk MV. Russ. J. Org. Chem. 2016; 52: 87
- 19a Das J, Chouhan R, Borgohain H, Borah BJ, Das SK. Synthesis 2023; 55: 2037
- 19b Colomer I, Urena M, Viso A, Fernandez de la Pradilla R. Chem. Eur. J. 2020; 26: 4620
- 19c Borgohain H, Talukdar K, Sarma B, Das SK. Org. Biomol. Chem. 2020; 18: 7401
- 19d Vanucci C, Brusson X, Verdel V, Zana F, Dhimane H, Lhommet G. Tetrahedron Lett. 1995; 36: 2971
- 20 For a review, see: te Grotenhuis C, Schoonen L, Rutjes FP. J. T. Cyanation of Epoxides. In C-1 Building Blocks in Organic Synthesis 2. Van Leeuwen PW. N. M. Thieme; Stuttgart: 2014
- 21 For a review on reductive amination, see: Afanasyev OI, Kuchuk E, Usanov DL, Chusov D. Chem. Rev. 2019; 119: 11857
- 22 Sheldrick GM. Acta Crystallogr., Sect. A 2008; 64: 112
- 23 CCDC 2345489 contains the supplementary crystallographic data for 6h·H2O. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures
- 24 Similar structure was observed for the spirocyclic hybrids of (1R,5S)-8-azabicyclo[3.2.1]octane with cyclobutanone and cyclopentanone; see: Gerasov A, Boiko R, Dolgonos G, Mandzhulo A, Shivanyuk A, Fetyukhin V, Lukin O. Synthesis 2022; 54: 723
- 25 CCDC 2345488 contains the supplementary crystallographic data for 14g·H2O. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures
- 26a Elstner M, Porezag D, Jungnickel G, Elsner J, Haugk M, Frauenheim T, Suhai S, Seifert G. Phys. Rev. B 1998; 58: 7260
- 26b Hourahine B, Aradi B, Blum V, Bonafé F, Buccheri A, Camacho C, Cevallos C, Deshaye MY, Dumitrică T, Dominguez A, Ehlert S, Elstner M, van der Heide T, Hermann J, Irle S, Kranz JJ, Köhler C, Kowalczyk T, Kubař T, Lee IS, Lutsker V, Maurer RJ, Min SK, Mitchell I, Negre C, Niehaus TA, Niklasson AM. N, Page AJ, Pecchia A, Penazzi G, Persson MP, Řezáč J, Sánchez CG, Sternberg M, Stöhr M, Stuckenberg F, Tkatchenko A, Yu VW.-z, Frauenheim T. J. Chem. Phys. 2020; 152: 124101
- 26c Grimme S, Antony J, Ehrlich S, Krieg H. J. Chem. Phys. 2010; 132: 154104
- 26d Gaus M, Goez A, Elstner M. J. Chem. Theory Comput. 2013; 9: 338
- 26e Gaus M, Lu X, Elstner M, Cui Q. J. Chem. Theory Comput. 2014; 10: 1518
- 27a Becke AD. J. Chem. Phys. 1988; 88: 1053
- 27b Lee CT, Yang WT, Parr RG. Phys. Rev. B 1988; 37: 785
- 27c Stephens PJ, Devlin FJ, Chabalowski CF, Frisch MJ. J. Phys. Chem. 1994; 98: 11623
- 27d Hariharan PC, Pople JA. Theor. Chim. Acta 1973; 28: 213
- 27e Grimme S, Ehrlich S, Goerigk L. J. Comput. Chem. 2011; 32: 1456
- 28a Rajagopal K, Kalusalingam A, Bharathidasan AR, Sivaprakash A, Shanmugam K, Sundaramoorthy M, Byran G. Molecules 2023; 28: 4175
- 28b Ntie-Kang F, Mbah JA, Lifongo LL, Owono Owono LC, Magnassan E, Meva’a Mbaze L, Judson PN, Sippl W, Efange SM. N. Org. Med. Chem. Lett. 2013; 3: 10
- 29 Schrödinger. Maestro, Version 2020-3. LLC; New York: 2020
- 30 Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Adv. Drug Deliv. Rev. 1997; 23: 3
- 31a Teague SJ, Davis AM, Leeson PD, Oprea TI. Angew. Chem. Int. Ed. 1999; 38: 3743
- 31b Hann MM, Oprea TI. Curr. Opin. Chem. Biol. 2004; 8: 255
- 32a Verdonk ML, Cole JC, Hartshorn ML, Murray CW, Taylor RD. Proteins 2003; 52: 609
- 32b Ursu O, Oprea TI. J. Chem. Inf. Model. 2010; 50: 1387
- 33 Aradi B, Hourahine B, Frauenheim T. J. Phys. Chem. A 2007; 111: 5678
- 34 Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA. Jr, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas Ö, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ. Gaussian 09, Revision D.01. Gaussian, Inc; Wallingford, CT: 2009
On the synthesis and biological activity of 1,3-oxazinan-2-ones, see: